Michael C James bought $41k of GTHP
director at GUIDED THERAPEUTICS INC. 412,945 shares at an average of $0.10, traded Mar 18, 2025, filed Apr 8, 2025.
Score components
- +15RoleDirector
- +6Trade size$41k at market
- +10Relative to holdingsHoldings up 366%
- 0Price contextNo price history yet
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +29.9%, 3m +257.1%, 6m +223.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001477932-25-002516, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 18, 2025 | POpen-market purchase Common Stock | +150,000 | $0.10 | $15k | 262,772 | Apr 8, 2025 |
| Mar 18, 2025 | POpen-market purchase Common Stock | +262,945 | $0.10 | $26k | 525,717 | Apr 8, 2025 |
| Mar 18, 2025 | POpen-market purchase Warrantsderivative | +150,000 | - | - | 150,000 | Apr 8, 2025 |
| Mar 18, 2025 | POpen-market purchase Warrantsderivative | +262,945 | - | - | 412,945 | Apr 8, 2025 |
Related signals
Other insiders at GUIDED THERAPEUTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | GUIDED THERAPEUTICS INC | Michael C James director | $5,000 27,778 shares | +5% | |
| 23Weak | GUIDED THERAPEUTICS INC | John E Imhoff director, owner | $30k 166,667 shares | +1% | |
| 37Weak | GUIDED THERAPEUTICS INC | John E Imhoff director, owner | $126k 1,263,069 shares | +8% | |
| 37Weak | GUIDED THERAPEUTICS INC | John E Imhoff director, owner | $126k 1,263,069 shares | +8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.